GGrantIndex
Sort

50,496 grants matching lung cancer

DNA Sequencing and FACS Core Facilities

$1,931,359
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression

$1,930,840
Sylvia Katina Plevritis · Stanford University · U54 · FY2025 · CA

Signal Processing And Instrumentation Section

$1,930,370
Thomas J Pohida · Center For Information Technology · ZIA · FY2019 · CT

Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking

$1,930,116
Stephen S Hecht · University Of Minnesota · P01 · FY2019 · CA

In Vivo Cellular and Molecular Imaging Center@Stanford

$1,926,940
Sanjiv S Gambhir · Stanford University · P50 · FY2014 · CA

Growth Factor Imaging and Photoimmunotherapy

$1,926,705
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Personalized therapeutics for inhibiting breast cancer metastasis

$1,925,413
Debra Auguste · City College Of New York · DP2 · FY2012 · CA

Studies of Occupational Cancer

$1,924,083
Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Epidemiology of putative genuine genetic variant: The Women's Health Intiative

$1,923,733
Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2008 · HG

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

$1,922,740
Quynh-Thu X Le · Stanford University · P01 · FY2024 · CA

Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study

$1,922,443
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Cellular and Molecular Mechanisms of Lung Disease

$1,920,915
Bruce A. Stanton · Dartmouth College · P20 · FY2009 · RR

Inflammation Pathways and COPD in the Development of Lung Cancer

$1,919,858
Ann G Schwartz · Wayne State University · R01 · FY2015 · CA

Genetic Variation in Cancer Risk and Outcomes in African Americans

$1,919,811
Ann G Schwartz · Wayne State University · P01 · FY2024 · CA

Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression

$1,919,101
Sylvia Katina Plevritis · Stanford University · U54 · FY2023 · CA

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)

$1,918,750
H-H. Sherry Chow · University Of Arizona · UG1 · FY2020 · CA

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)

$1,918,750
H-H. Sherry Chow · University Of Arizona · UG1 · FY2021 · CA

Human Immune Responses to Tumor Antigens for Cancer Immunotherapy

$1,918,695
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Molecular Diagnostics Core Laboratory

$1,918,162
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

Epidemiology of putative genuine genetic variant: The Women's Health Intiative

$1,916,734
Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2010 · HG

PLCO Trial Etiologic and Early Marker Study

$1,915,866
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

New Targets for Therapy for Adenocarcinoma of the Lung

$1,915,760
Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA

Role of microbiome in cancer and inflammation

$1,915,729
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

University of Iowa - Research 3T MRI Connectome Upgrade

$1,915,271
Vincent A Magnotta · University Of Iowa · S10 · FY2018 · OD

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

$1,913,603
Siddarth Selvaraj · Arima Genomics, Inc. · R44 · FY2024 · CA